News

Calyxt to Break Ground on New Concept-to-Fork Facility in Roseville, Minn.

Minneapolis-St. Paul, Minn., September 6, 2017 – Following a successful initial public offering (IPO) in July 2017, Calyxt, Inc. (NASDAQ:CLXT), a consumer-centric, food- and agriculture-focused company, today announced that the Company will break ground on its new concept-to-fork facility in Roseville, Minn., on Thursday, Sept. 7, 2017, at 9 a.m. CT. The 11-acre site will […]

Read More

Calyxt Announces Full Exercise of Over-Allotment Option and Closing of its Initial Public Offering

  St. Paul, Minn. and New York, NY, July 25, 2017 – Cellectis S.A. (NASDAQ: CLLS) and Calyxt, Inc. (NASDAQ: CLXT) announced today the closing of Calyxt’s initial public offering of 8,050,000 shares of its common stock at the initial public offering price of $8.00 per share (the “Offering”). The number of shares issued in […]

Read More

Calyxt Announces Pricing of $56.0 Million Initial Public Offering

  St. Paul, Minn. and New York, NY, July 19, 2017 – Cellectis S.A. and Calyxt, Inc. announced today the pricing of Calyxt’s initial public offering of 7,000,000 shares of its common stock at the initial public offering price of $8.00 per share (the “Offering”).  The number of shares in the Offering represents an increase […]

Read More

Calyxt Announces Proposed Initial Public Offering of $100.0 Million

  St. Paul, Minn. and New York, NY, July 10, 2017 – Cellectis S.A. (Alternext: ALCLS; Nasdaq: CLLS) and Calyxt, Inc. announced today that Calyxt has commenced a proposed initial public offering of 6,060,606 shares of Calyxt’s common stock pursuant to a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC). […]

Read More

Calyxt Files Registration Statement for Proposed Initial Public Offering

  St. Paul, Minn. and New York, NY, June 23, 2017 – Cellectis S.A. (Alternext : ALCLS ; Nasdaq : CLLS) and Calyxt, Inc. announced that Calyxt has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering (IPO) of shares of […]

Read More

Calyxt Names Joseph B. Saluri as General Counsel & EVP, Corporate Development

  St. Paul, Minn., June 7, 2017 — Calyxt, Inc., a Minnesota-based company developing healthier specialty food ingredients to benefit both consumers and farmers, has named Joseph B. Saluri as General Counsel and Executive Vice President, Corporate Development. Mr. Saluri brings to Calyxt over 24 years of legal, business development, strategic planning and project management […]

Read More

Calyxt Launches U.S. Field Trials with University of Minnesota for Powdery Mildew-Resistant Spring Wheat Variety

  Wheat Marks Calyxt’s Fourth Gene Edited Crop to Undergo Trials   Minneapolis-St. Paul, Minn., May 16, 2017 – Calyxt, Inc., a Minnesota-based company developing healthier specialty food ingredients to benefit both consumers and farmers, today announced that the Company, under a service agreement with the University of Minnesota, has launched field trials in the […]

Read More

Calyxt Patent Encompassing Broad Uses of Plant Gene Editing Technologies Maintained by USPTO

U.S. Patent 8,921,332 Refers to the Use of Chimeric Endonucleases, such as Zinc Finger Nucleases, TAL-effector Nucleases, Mega-TALs and CRISPR/Cas9 to Precisely Edit DNA within Plant Genomes   Minneapolis-St. Paul, Minn., May 10, 2017 — Calyxt, Inc., a Minnesota-based company developing healthier food products to benefit both consumers and farmers, today announced that U.S. patent […]

Read More

Calyxt Hires Cargill Executive Manoj Sahoo as Chief Commercial Officer

  St. Paul, Minn., March 21, 2017 — Calyxt, Inc., a Minnesota-based company developing healthier food products to benefit both consumers and growers, announced today that former Cargill executive Manoj Sahoo is joining Calyxt as the Company’s Chief Commercial Officer. Mr. Sahoo will work closely as part of Calyxt’s executive team to build a commercial […]

Read More

Calyxt Announces New Technology Framework Agreement with Plant Bioscience Limited to Expand IP Portfolio

  St. Paul, Minn., March 9, 2017 – Calyxt, Inc., a Minnesota-based company developing healthier food products to benefit both consumers and growers, announced today that the Company has signed a technology framework agreement with Plant Bioscience Limited (PBL) to expand Calyxt’s intellectual property (IP) portfolio to include new product-based IP from leading academic institutions […]

Read More

Calyxt Appoints Seed & Trait Veteran Bryan Corkal to New Chief Financial Officer Role

Expansion of Senior Leadership Team Further Solidifies Calyxt’s Mission to Bring Foods with Healthier Characteristics to Market Faster & More Efficiently St. Paul, Minn., Dec. 5, 2016 — Calyxt, Inc., a Minnesota-based company developing healthier food products to benefit both consumers and growers, announced today the appointment of former Monsanto executive Bryan Corkal  to the […]

Read More

Calyxt Produces 1,200 Tons of High-Oleic Soybeans in U.S.

  Minneapolis-St. Paul, Minn., November 15, 2016 – Calyxt, Inc., a Minnesota-based company developing healthier food products to benefit both consumers and growers, today announced that the Company has completed the 2016 expansion of its high-oleic/no trans-fat soybean variety (CAL1501) in the U.S. with a production of 1,200 tons of beans. In Spring 2016, Calyxt […]

Read More

Calyxt Generating Healthier High-Oleic Low-Linolenic Soybean Variety with Increased Oxidative Stability and Enhanced Shelf Life

  Article Available in BMC Plant Biology   Minneapolis-St. Paul, Minn., October 31, 2016 – Calyxt, Inc., a Minnesota-based company developing healthier food products to benefit both consumers and growers, today announced the publication of a study in BMC Plant Biology describing the use of genome editing technology to modulate soybean oil composition to have […]

Read More

Calyxt Expands its Patent Portfolio, Now Encompassing Broad Uses of Technologies such as CRISPR/Cas9, Zinc Finger Nucleases and TAL-effector Nucleases for Plant Gene Editing

U.S. Patents 9,458,439 and 8,921,332 are Now Issued   Minneapolis-St. Paul, Minn., October 4, 2016 — Calyxt, Inc., a Minnesota-based company developing healthier food products to benefit both consumers and growers, today announced the issuance of U.S. patent 9,458,439, which claims broad gene inactivation by use of chimeric restriction endonucleases, including TALEN® and CRISPR/Cas9 gene […]

Read More

Calyxt Completes Production of 30 Tons of its High Oleic Soybean Product in Argentina

  St. Paul, Minn., May 24, 2016 — Calyxt, Inc., a Minnesota-based company focusing on developing healthier products to benefit both consumers and growers, today announced that it has completed the expansion of its high oleic/no trans fat soybean variety in Argentina, as part of its counter-season seed production. Thirty tons of high oleic/no trans […]

Read More

Calyxt Appoints Federico A. Tripodi to New Role of CEO

  St. Paul, Minn., May 23rd, 2016 — Calyxt, Inc., a Minnesota-based company developing healthier food products to benefit both consumers and growers, announced today the appointment of former Monsanto Corporation executive Federico A. Tripodi to the role of Chief Executive Officer of Calyxt. Mr. Tripodi will work closely with Calyxt’s executive team and researchers to […]

Read More

Calyxt Acquires Land for New Headquarters Facility

  St. Paul, Minn., March 1st, 2016 — Calyxt, Inc., a Minnesota-based company focusing on developing healthier food products to benefit both consumers and growers, today announced that it has closed on the purchase of a 10-acre parcel in the St. Paul suburb of Roseville to build its new headquarters facility. The new facility which […]

Read More

Calyxt Announces Research Collaboration and Licensing Agreement for Trait Development in Wheat, Rice and Corn

  December 16, 2015 — New Brighton, Minn. — Calyxt, Inc., a Minnesota-based company focused on developing healthier food products to benefit both consumers and farmers, today announced that it has signed a research collaboration and option to exclusive licenses with Plant Bioscience Limited (PBL) for certain new crop plants developed using gene editing by the Institute of Genetics and Developmental Biology […]

Read More

Calyxt Completes the First Field Trials of its Cold Storable Potato Product

  November the 2nd, 2015 — New Brighton (Minnesota, USA) — Calyxt, Inc., a Minnesota-based company focusing on developing healthier food products to benefit both consumers and farmers, today announced that it has completed the first field trials in Minnesota, Wisconsin and Michigan of its cold storable potato. A significant amount of potatoes harvested each […]

Read More

Calyxt Completes Second Year of Field Trials of its High Oleic Soybean Product

  November the 2nd, 2015 — New Brighton (Minnesota, USA) — Calyxt, Inc., a Minnesota-based company focusing on developing healthier food products to benefit both consumers and farmers, today announced that it has completed the second year of multi-location field trials in Minnesota and South Dakota of its high oleic/no trans fat soybean variety. For many […]

Read More

University of Minnesota Grants Calyxt an Exclusive License to its Homologous Recombination Technology in Plants

  July 28, 2015 —New Brighton (Minnesota, USA) — Calyxt, Inc., a Minnesota-based company focusing on developing healthier food products, today announced that it has signed an exclusive license agreement with the University of Minnesota that grants Cellectis the worldwide rights to use the technology covered by the patent rights of the family PCT/US2013/046495 entitled […]

Read More

Calyxt Announces a Publication in Molecular Plant Journal Demonstrating Non-Transgenic Plant Genome Editing Using Protein Delivery of Nucleases

  July 23, 2015 — New Brighton (Minnesota, USA) — Calyxt, Inc., a Minnesota-based company focusing on developing healthier food products, has announced today that Molecular Plant, a Cell Press Journal, has accepted the publication of its peer-reviewed manuscript demonstrating targeted gene editing using nucleases purified as proteins. The results demonstrate that sequence-specific nucleases (both […]

Read More

Calyxt, Inc. subsidiary of Cellectis among the 50 Smartest Companies 2015 by MIT Technology Review

Read more

Read More

Calyxt boosts its wheat pipeline

  July 15, 2015 — New Brighton (Minnesota, USA) — Calyxt, Inc., a Minnesota-based company focusing on developing healthier food products, today announced that it has signed an exclusive license agreement with Plant Bioscience Limited (PBL) for a bread wheat trait generated using gene editing. The trait provides endogenous resistance to powdery mildew of wheat, a fungus widely distributed throughout the world, responsible for major grain and yield losses. […]

Read More

Calyxt Launches Field Trials of High Oleic Soybean

  July 8, 2015 — New Brighton (Minnesota, USA) — Calyxt, Inc., a Minnesota-based company focusing on developing healthier food products, today announced that it has started multi-location field trials in Argentina and in the U.S. of its high oleic/low trans fat soybean variety. Calyxt has previously generated and validated the healthier, high oleic soybean oil in […]

Read More

Calyxt Launches Field Trials of its Cold Storable Potato

  July 8, 2015 — New Brighton (Minnesota, USA) — Calyxt, Inc., a Minnesota-based company focusing on developing healthier food products, today announced that it has started the field trials of its cold storable potato. Calyxt has previously validated in the greenhouse its potatoes developed by inactivating a single endogenous gene responsible for sugar accumulation […]

Read More

S&W Seed Company and Calyxt, Inc. Announce Alfalfa Seed Collaboration

  Companies to apply next generation gene editing technology to the alfalfa seed industry     FRESNO, California and NEW BRIGHTON, Minnesota – June 9, 2015 – S&W Seed Company (Nasdaq: SANW), a leading provider of seed genetics, production, processing and marketing for the alfalfa seed market, and Calyxt, Inc., a Minnesota-based company focusing on developing healthier food […]

Read More

Calyxt Appoints Chief Financial Officer

  May 27, 2015 — New Brighton (Minnesota, USA) — Calyxt, Inc., a Minnesota-based company focusing on developing healthier food products, today announced the appointment of Gregory R. Smith as Chief Financial Officer. With over 25 years in both public and private companies, Mr. Smith has served in various management roles including CFO and Vice […]

Read More

Cellectis Plant Sciences Becomes Calyxt

  May 4, 2015 — New Brighton (Minnesota, USA) — Cellectis plant sciences, Inc., a Minnesota-based Company focusing on developing healthier food products, announced today that it has changed its corporate name to Calyxt, Inc. The company will use this new name as of today. The new name reflects the Company’s exclusive focus and expertise […]

Read More

Cellectis Plant Sciences, Inc. Locks Early CRISPR Intellectual Property Uses in Plants

Cellectis plant sciences entered in an exclusive license agreement with Regents of the University of Minnesota covering certain uses of CRISPR technology   April 15, 2015 — New Brighton (Minnesota, USA) — Cellectis plant sciences, Inc., a Minnesota-based Company focusing on developing healthier food products, has announced today that it has signed an exclusive license […]

Read More

Cellectis Plant Sciences, Inc. Publishes a Study Demonstrating Reduced Acrylamide in Fried Potatoes

  April 14, 2015 — New Brighton (Minnesota, USA) — Cellectis Plant Sciences, Inc. a Minnesota-based company focusing on developing healthier food products, has announced today that the Plant Biotechnology Journal has accepted the publication of its peer-reviewed manuscript demonstrating the phenotypic validation of potato lines developed by inactivating a single endogenous gene responsible for […]

Read More

Cellectis Plant Sciences and Two Blades Foundation Announce the Execution of a Cross-License Agreement on TAL Effector Nuclease Technologies

  December 18, 2014 — New Brighton (Minnesota, USA) and Evanston (Illinois, USA) — Cellectis plant sciences, a Minnesota-based company focusing on developing healthier food products, and the Two Blades Foundation (2Blades) today announced the execution of a non-exclusive cross-license agreement relating to TAL nuclease technologies. Pursuant to the agreement, 2Blades receives a license to […]

Read More

Cellectis plant sciences CSO Dan Voytas honored as Entrepreneurial Researcher of the Year by the University of Minnesota

December 12, 2014 View the article and video here

Read More

Cellectis plant sciences CEO Luc Mathis interviewed in Seed World Magazine

December 3, 2014 View article here

Read More

Cellectis plant sciences launches its new website

  New Brighton (Minnesota, USA), September 29, 2014 – Cellectis plant sciences, the plant genome engineering company, is proud to announce today the launch of its new website www.cellectis-plantsciences.com. Based in Minnesota, Cellectis plant sciences develops healthier products in four major crops: potato, soybean, wheat and canola. This new website is designed to offer quick […]

Read More

Cellectis plant sciences reports improvement of oil content in algae

  New Brighton (Minnesota, USA), May 29, 2014 – Cellectis (Paris:ALCLS) plant sciences, the plant genome engineering company, today announced the publication in Nature Communications the development of algae strains with improved and increased oil content. Diatoms are among the world’s most important microalgae, both in terms of diversity and relevance for biotechnological applications. Triacyglycerol […]

Read More

Cellectis plant sciences reports generation of High Oleic Soybean in Journal of Plant Biotechnology

  New Brighton (Minnesota, USA), May 23, 2014 – Cellectis (Paris:ALCLS) plant sciences, the plant genome engineering company, today announced the peer-reviewed publication in the Journal of Plant Biotechnology of results demonstrating the generation of a high oleic soybean variety created by the targeted gene editing of 4 alleles of the FAD2 gene family. The […]

Read More

Cellectis plant sciences and Bayer CropScience extend their partnership to improve crops by gene editing

  New Brighton (Minnesota, USA), January 30, 2014 – Cellectis plant sciences, the plant genome engineering company and subsidiary of Cellectis SA (Alternext: ALCLS), has signed two new agreements with Bayer CropScience, a subsidiary of Bayer AG and a leader in the areas of seeds, crop protection and non-agricultural pest control, on gene editing in […]

Read More

Cellectis plant sciences announce the finalization of the first glycosylation lines of their program

  New Brighton (Minnesota, USA), January 9, 2014 – Cellectis plant sciences, the plant genome engineering specialist, today announced the attainment of an important milestone in its collaboration with Medicago Inc. (Quebec City, Canada). In January 2012 Cellectis and Medicago entered into a research agreement to improve therapeutic proteins expressed from tobacco leaves. At this […]

Read More

Cellectis plant sciences CEO Luc Mathis joins Board of Directors of the French Association for Plant Biotechnology (AFBV)

  Paris, June 6, 2013 – Cellectis (NYSE Alternext: ALCLS), the global genome engineering specialist, announced today that Luc Mathis, Cellectis plant sciences CEO, has been elected to the Board of Directors of the French Association for Plant Biotechnology (Association Française des Biotechnologies Végétales, AFBV). The French Association for Plant Biotechnology (AFBV) is an independent […]

Read More

Medicago and Cellectis Successfully Achieve First Step in Research Collaboration

Progress made towards production of biosimilar products in tobacco plants   Quebec City (Quebec, Canada) and Saint Paul (Minnesota, USA), October 4, 2012 – Medicago Inc. (TSX: MDG; OTCQX: MDCGF), (“Medicago”) a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus Like Particles (“VLP”s), and Cellectis plant […]

Read More

Cellectis plant sciences announces the signature of a strategic partnership with SESVanderHave in Sugar Beet

  Saint Paul (Minnesota, USA), January 31st, 2012 – Cellectis plant sciences, the plant genome engineering company and subsidiary of Cellectis (Alternext: ALCLS), announces today the signature of a research and commercial agreement with SESVanderHave, a world leader in the sugar beet seed industry, on the use of Cellectis technologies in sugar beet. The agreement […]

Read More

Changes in the Group’s Scientific Division and appointment of the CEO of Cellectis Plant Science

  Paris, January 30th, 2012 – Cellectis  (Paris:ALCLS)(Alternext: ALCLS), the French genome engineering specialist, is announcing the operational withdrawal of Frédéric Pâques, who has joined the Group’s Scientific Advisory Board, as well as three appointments in its Scientific Division: Jean-Charles Epinat as Chief Technology Officer, Philippe Duchâteau as Chief Scientific Officer, and Frédéric Cédrone as […]

Read More

Cellectis plant sciences and Bayer CropScience strengthen genome engineering partnership

  Saint Paul (Minnesota, USA), January 3, 2012 – Cellectis plant sciences, the plant genome engineering company and subsidiary of Cellectis (Alternext: ALCLS), today announced that it has signed a research and commercial agreement with Bayer CropScience AG, a subsidiary of Bayer AG and a leader in crop protection, non-agricultural pest control, seeds and plant […]

Read More